IL6 and Insulin resistance: As chronic inflammation has been proven to play an essential role in insulin resistance and metabolic syndrome15,16, we measured inflammatory cytokines in peripheral blood and concluded that RYGB substantially reduced systemic inflammation, as supported by the finding that IL6 and TNFα were decreased in the RYGB group.